ADIMAB INC has a total of 12 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Mexico. Its main competitors in its focus markets biotechnology, organic fine chemistry and computer technology are DUTALYS GMBH, ADIMAB LLC and OSSIANIX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | China | 2 | |
#3 | Mexico | 2 | |
#4 | United States | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Computer technology | |
#4 | Pharmaceuticals | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Combinatorial chemistry | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Bioinformatics | |
#6 | Analysing materials | |
#7 | Computational chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Gerngross Tillman U | 6 |
#2 | Vasquez Maximiliano | 6 |
#3 | Feldhaus Michael | 6 |
#4 | Wittrup K Dane | 5 |
#5 | K Dane Wittrup | 3 |
#6 | Michael Feldhaus | 3 |
#7 | Tillman U Gerngross | 2 |
#8 | Hua Shaobing | 2 |
#9 | Maximiliano Vasquez | 2 |
#10 | Zhu Li | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010105256A1 | Rationally designed, synthetic antibody libraries and uses therefor | |
WO2010065711A1 | An abcb5 epitope and antibodies thereto for the treatment of cancer | |
CA2697193A1 | Rationally designed, synthetic antibody libraries and uses therefor |